Tissue factor-dependent procoagulant activity of isolated human hepatocytes: Relevance to liver cell transplantation

Liver Transplantation

Volumn 13, Issue 4, 2007, Pages 599-606

  Stéphenne, Xavier ^a   Vosters, Olivier ^a,b   Najimi, Mustapha ^a   Beuneu, Claire ^b   Ngoc, Dung Khuu ^a   Wijns, Walter ^c   Goldman, Michel ^b   Sokal, Etienne M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; D DIMER; PROCOAGULANT; THROMBOPLASTIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CELL ISOLATION; CELL SUSPENSION; CONTROLLED STUDY; CRIGLER NAJJAR SYNDROME; CRYOPRESERVATION; FLOW CYTOMETRY; GRAFT RECIPIENT; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOOD COAGULATION; CELL TRANSPLANTATION; CRYOPRESERVATION; HEPATOCYTES; HUMANS; LIVER TRANSPLANTATION; RNA, MESSENGER; THROMBOPLASTIN;

EID: 34247261030     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21128     Document Type: Article

References (33)

1. Fox IJ, Chowdbury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422-1426.
2. Najimi M, Sokal E. Liver cell transplantation. Minerva Pediatr 2005;57:243-257.
3. Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 2003;76:735-738.
4. Stephenne X, Najimi M, Smets F, Reding R, de Ville dG, Sokal EM. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 2005;5:2058-2061.
5. Stephenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 2006;130:1317-1323.
6. Fisher RA, Bu D, Thompson M, Tisnado J, Prasad U, Sterling R, et al. Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion. Transplantation 2000;69:303-307.
7. Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 2000;105:125-133.
8. Beuneu C, Vosters O, Movahedi B, Remmelink M, Salmon I, Pipeleers D, et al. Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation. Diabetes 2004;53:1407-1411.
9. Johansson H, Lukinius A, Moberg L, Lundgren T, Berne C, Foss A, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005;54:1755-1762.
10. Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002;360:2039-2045.
11. Beuneu C, Vosters O, Ling Z, Pipeleers D, Pradier O, Goldman M, Verhasselt V. N-Acetylcysteine derivative inhibits procoagulant activity of human islet cells. Diabetologia 2006;50:343-347.
12. Ungerstedt JS, Heimersson K, Soderstrom. T, Hansson M. Nicotinamide inhibits endotoxin-induced monocyte tissue factor expression. J Thromb Haemost 2003;1:2554-2560.
13. Darwish AA, Sokal E, Stephenne X, Najimi M, de Ville de Goyet J, Reding R. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl 2004;10:1213-1215.
14. Knudsen TT, Thorsen S, Jensen SA, Dalhoff K, Schmidt LE, Becker U, Bendtsen F. Effect of intravenous N-acetyl-cysteine infusion on haemostatic parameters in healthy subjects. Gut 2005;54:515-521.
15. Bertuzzi F, Marzorati S, Maffi P, Piemonti L, Melzi R, de Taddeo F, et al. Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type I diabetic recipients. J Clin Endocrinol Metab 2004;89:5724-5728.
16. Basista MH, Stieffenhofer A, Kim DG, Murase N, Todo S, Dindzans VJ. Procoagulant activity and tumor necrosis factor in rat hepatic allograft rejection. Hepatology 1991; 14:883-887.
17. Arai M, Mochida S, Ohno A, Fujiwara K. Blood coagulation in the hepatic sinusoids as a contributing factor in liver injury following orthotopic liver transplantation in the rat. Transplantation 1996;62:1398-1401.
18. Nakao A, Iwaki Y, Virji MA, Kita Y, Demetris AJ, Iwatsuki S, Starzl TE. Normotest and abnormal prothrombin in liver transplantation. Liver 1995;15:260-264.
19. Bumgardner GL, Li J, Prologo JD, Heininger M, Orosz CG. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection. Transplantation 1999;68:555-562.
20. Bumgardner GL, Gao D, Li J, Baskin JH, Heininger M, Orosz CG. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice. Transplantation 2000;70:1771-1780.
21. Gao D, Li J, Orosz CG, Bumgardner GL. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice. Hepatology 2000;32:1018-1028.
22. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989;134:1087-1097.
23. Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor anti-body. Thromb Res 1990;59:421-437.
24. Wojta J, Nakamura T, Fabry A, Hufnagl P, Beckmann R, McGrath K, Binder BR. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. Blood 1994;84:151-157.
25. Muraca M, Neri D, Parenti A, Feltracco P, Granato A, Vilei MT, et al. Intraportal hepatocyte transplantation in the pig: hemodynamic and histopathological. study. Transplantation 2002;73:890-896.
26. Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol 2002;24:243-251.
27. Hermans C, Dessomme B, Lambert C, Deneys V. Malformations veineuses et coagulopathie. [Venous malformations and coagulopathy.] Ann Chir Plast Esthet 2006;51: 388-393. [French]
28. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991;303:1026-1029.
29. Bajt ML, Knight TR, Lemasters JJ, Jaeschke H. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol Sci 2004;80:343-349.
30. Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther 2005;312:509-516.
31. Regueira FM, Cienfuegos JA, Pardo F, Hernandez JL, Diez-Caballero A, Sierra A, et al. Improvement in early function of the hepatic graft after treatment of the donor with N-acetylcysteine: clinical study. Transplant Proc 1997;29:3350-3352.
32. Bromley PN, Cottam SJ, Hilmi I, Tan KC, Heaton N, Ginsburg R, Potter DR. Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation. Br J Anaesth 1995; 75:352-354.
33. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-1857.